COURTNEY DAVIES: Open Payments
NPI 1083442040 · DUNMORE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,890 in 173 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $556 · 2025 $2,890
Food & beverage: $2,890
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 32 | $603 |
| AstraZeneca Pharmaceuticals LP | 8 | $344 |
| ABBVIE INC. | 12 | $315 |
| Amgen Inc. | 32 | $256 |
| Lilly USA, LLC | 21 | $231 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $192 |
| Kowa Pharmaceuticals America, Inc. | 10 | $172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $155 |
| GlaxoSmithKline, LLC. | 9 | $138 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
Products named: BREZTRI, Ozempic, JARDIANCE, XIFAXAN, REXULTI, Rybelsus, ZORYVE, OTEZLA.
Industry payments across PA — which companies pay providers there.
